Hunis, Narcisa .

HRN: 23-35-21  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/27/2026
CLINDAMYCIN 300MG (CAP)
03/27/2026
04/03/2026
PO
300mg
Q8H
Infected Wound
Pending Pharmacy Acceptance 

 Indication:  Empirical De-escalation    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: